Analytical Data
-
基因名
Rep78
- Application
-
别名
Rep78；BTB/POZ domain-containing Protein KCTD5
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9NXV2
-
表达区间
1-234aa
-
氨基酸序列
MAENHCELLSPARGGIGAGLGGGLCRRCSAGLGALAQRPGSVSKWVRLNVGGTYFLTTRQTLCRDPKSFLYRLCQADPDLDSDKDETGAYLIDRDPTYFGPVLNYLRHGKLVINKDLAEEGVLEEAEFYNITSLIKLVKDKIRERDSKTSQVPVKHVYRVLQCQEEELTQMVSTMSDGWKFEQLVSIGSSYNYGNEDQAEFLCVVSKELHNTPYGTASEPSEKAKILQERGSRM
-
分子量
26kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Recombinant Human MRPL39 Protein，His
Cat：PA2000-9464
Recombinant Human CRMP5 Protein，His
Cat：PA2000-929DB
Protein Description
Rep78 protein, derived from the adeno-associated virus type 2 (AAV2), plays a crucial role in the virus's life cycle and is essential for its replication and gene expression. This protein, encoded by the rep gene, is responsible for the regulation of viral replication, encapsidation, and the transition of the viral lifecycle. Research into Rep78 has gained interest due to its potential applications in gene therapy and biotechnology, particularly as a tool for delivering therapeutic genes to target cells. The AAVs, being non-pathogenic and capable of infecting both dividing and non-dividing cells, make Rep78 an appealing candidate for developing novel gene delivery systems. Studies have shown that modulating Rep78 expression and function can enhance the efficiency of AAV vectors, improving their effectiveness in therapeutic applications. Furthermore, understanding the molecular mechanisms that govern Rep78's function could lead to insights into viral behavior and the development of strategies to harness or inhibit viral processes for therapeutic benefits. Thus, the ongoing research into Rep78 not only deepens our understanding of AAV biology but also paves the way for innovative advancements in gene therapy and regenerative medicine.
